• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Efficacy and safety of DVD and VAD regimens in patients with newly diagnosed multiple myeloma].

作者信息

Liu W J, Wang W D, Wang H, Wang J H, Lyu Y

机构信息

Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):542-544. doi: 10.3760/cma.j.issn.0253-2727.2017.06.015.

DOI:10.3760/cma.j.issn.0253-2727.2017.06.015
PMID:28655101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7342975/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3aef/7342975/c9c8578d80a1/cjh-38-06-542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3aef/7342975/52890fec3e31/cjh-38-06-542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3aef/7342975/c9c8578d80a1/cjh-38-06-542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3aef/7342975/52890fec3e31/cjh-38-06-542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3aef/7342975/c9c8578d80a1/cjh-38-06-542-g002.jpg

相似文献

1
[Efficacy and safety of DVD and VAD regimens in patients with newly diagnosed multiple myeloma].[DVD和VAD方案治疗新诊断多发性骨髓瘤患者的疗效与安全性]
Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):542-544. doi: 10.3760/cma.j.issn.0253-2727.2017.06.015.
2
Clinical benefits and economic analysis of pegylated liposomal doxorubicin/vincristine/dexamethasone versus doxorubicin/vincristine/dexamethasone in patients with newly diagnosed multiple myeloma.聚乙二醇化脂质体阿霉素/长春新碱/地塞米松与阿霉素/长春新碱/地塞米松治疗新诊断多发性骨髓瘤患者的临床疗效及经济分析
Clin Lymphoma Myeloma. 2007 Apr;7 Suppl 4:S150-5. doi: 10.3816/clm.2007.s.016.
3
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial.聚乙二醇化脂质体阿霉素、长春新碱和地塞米松与阿霉素、长春新碱和地塞米松相比，可显著降低新诊断的多发性骨髓瘤患者的毒性：一项III期多中心随机试验。
Cancer. 2006 Feb 15;106(4):848-58. doi: 10.1002/cncr.21662.
4
Role of liposomal anthracyclines in the treatment of multiple myeloma.脂质体蒽环类药物在多发性骨髓瘤治疗中的作用。
Semin Oncol. 2004 Dec;31(6 Suppl 13):147-60. doi: 10.1053/j.seminoncol.2004.08.005.
5
New treatment strategies for multiple myeloma.多发性骨髓瘤的新治疗策略。
Semin Hematol. 2004 Oct;41(4 Suppl 7):2-8. doi: 10.1053/j.seminhematol.2004.09.002.
6
[Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma].沙利度胺联合地塞米松治疗初诊多发性骨髓瘤的疗效
Ai Zheng. 2007 Dec;26(12):1369-72.
7
[Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].[采用长春新碱-阿霉素-地塞米松方案治疗晚期多发性骨髓瘤患者的结果]
Srp Arh Celok Lek. 1996 Nov-Dec;124(11-12):292-6.
8
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.多柔比星脂质体联合长春新碱和地塞米松（VAD）静脉推注与普通多柔比星联合长春新碱和地塞米松（VAD）作为多发性骨髓瘤一线治疗的前瞻性随机对照研究
Ann Oncol. 2003 Jul;14(7):1039-44. doi: 10.1093/annonc/mdg287.
9
VAD regimen in the treatment of resistant multiple myeloma: slow or fast infusion?VAD方案治疗难治性多发性骨髓瘤：慢速还是快速输注？
Leuk Lymphoma. 1993 Jul;10(4-5):347-51. doi: 10.3109/10428199309148559.
10
VAD-based regimens as primary treatment for multiple myeloma.基于VAD的方案作为多发性骨髓瘤的主要治疗方法。
Am J Hematol. 1990 Feb;33(2):86-9. doi: 10.1002/ajh.2830330203.

本文引用的文献

1
Novel drug combinations for the management of relapsed/refractory multiple myeloma.用于治疗复发/难治性多发性骨髓瘤的新型药物组合。
Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S71-7. doi: 10.1016/j.clml.2014.06.016.
2
Outcomes of autologous transplantation for multiple myeloma according to different induction regimens.根据不同诱导方案的多发性骨髓瘤自体移植结果。
Rev Bras Hematol Hemoter. 2014;36(1):19-24. doi: 10.5581/1516-8484.20140008.
3
Efficacy and safety of pegylated liposomal Doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome.
多柔比星脂质体与硼替佐米联合治疗多发性骨髓瘤的疗效和安全性：不良预后因素对疗效的影响。
Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):44-9. doi: 10.3816/CLML.2011.n.005.
4
Weekly bortezomib, pegylated liposomal doxorubicin, and dexamethasone is a safe and effective therapy for elderly patients with relapsed/refractory multiple myeloma.硼替佐米、聚乙二醇脂质体阿霉素和地塞米松每周方案治疗复发/难治性老年多发性骨髓瘤患者安全且有效。
Clin Lymphoma Myeloma Leuk. 2010 Feb;10(1):68-72. doi: 10.3816/CLML.2010.n.008.
5
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma.骨髓检查在确定多发性骨髓瘤患者对治疗的完全缓解中的重要性。
Blood. 2009 Sep 24;114(13):2617-8. doi: 10.1182/blood-2009-01-198788. Epub 2009 Jul 29.
6
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial.聚乙二醇化脂质体阿霉素、长春新碱和地塞米松与阿霉素、长春新碱和地塞米松相比，可显著降低新诊断的多发性骨髓瘤患者的毒性：一项III期多中心随机试验。
Cancer. 2006 Feb 15;106(4):848-58. doi: 10.1002/cncr.21662.
7
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.多柔比星脂质体联合长春新碱和地塞米松（VAD）静脉推注与普通多柔比星联合长春新碱和地塞米松（VAD）作为多发性骨髓瘤一线治疗的前瞻性随机对照研究
Ann Oncol. 2003 Jul;14(7):1039-44. doi: 10.1093/annonc/mdg287.
8
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.聚乙二醇化脂质体阿霉素、长春新碱和低剂量地塞米松联合治疗新诊断多发性骨髓瘤患者的II期试验。
Cancer. 2002 Nov 15;95(10):2160-8. doi: 10.1002/cncr.10946.
9
Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.美法仑和泼尼松联合长春新碱、卡莫司汀、美法仑、环磷酰胺及泼尼松治疗多发性骨髓瘤的比较：东部肿瘤协作组E2479研究结果
Cancer. 1997 Apr 15;79(8):1561-7.
10
Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.多发性骨髓瘤的治疗。采用不同美法仑剂量方案的联合化疗。
JAMA. 1969 Jun 2;208(9):1680-5. doi: 10.1001/jama.208.9.1680.